Takeaways: Silo Pharma’s CIPO Notice of Allowance for SPC‑15 strengthens its IP moat around a prophylactic, intranasal 5‑HT4 agonist approach for PTSD and stress‑induced disorders, complementing a rec...
Takeaways: Grey Matter’s focused ultrasound platform aims to offer a non‑invasive option for people whose depression hasn’t improved with medications or therapy, by precisely stimulating deep brain ci...
